Division of Metabolic and Cardiovascular Research, Department of Cardiovascular Medicine, Faculty of Life Sciences, Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Division of Cardiology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Cardiovasc Interv Ther. 2021 Jan;36(1):81-90. doi: 10.1007/s12928-020-00649-3. Epub 2020 Feb 12.
Although there is accumulating evidence for the usefulness of imaging-guided percutaneous coronary intervention (PCI), there are few studies for acute coronary syndrome (ACS), and the impact of the frequency of use has not been well addressed. From the Kumamoto Intervention Conference Study; a Japanese registry comprising 17 institutions, consecutive patients undergoing successful PCI from April 2008 through March 2014 were enrolled. Subjects were divided into two groups: imaging-guided PCI and angiography-guided PCI. Clinical outcome was a composite of cardiac death, non-fatal myocardial infarction, and stent thrombosis within 1 year. A total of 6025 ACS patients were enrolled: 3613 and 2412 patients with imaging- and angiography-guided PCI, respectively. Adverse cardiac events were significantly lower in the imaging-guided PCI group (long-rank P < 0.001). Even after propensity-score matching, the event rates still showed significant differences between the two groups (log-rank P = 0.004). To assess the effects of frequency of imaging usage, we divided the 17 institutions into six low-, six moderate-, and five high-frequency groups. The event rates decreased depending on the frequency, seemingly driven by stepwise event suppression in angiography-guided PCI. In Japanese ACS patients, the incidence of adverse clinical events in patients treated with imaging-guided PCI were significantly lower than that in patients with angiography-guided PCI. Better clinical result was found in the institutions using intravascular imaging more frequently. University Hospital Medical Information Network (UMIN)-CTR ( http://www.umin.ac.jp/ctr/ ). Identifier: KICS (UMIN000015397).
尽管越来越多的证据表明影像引导经皮冠状动脉介入治疗(PCI)的有用性,但针对急性冠状动脉综合征(ACS)的研究较少,且其使用频率的影响尚未得到很好的解决。这项研究来自 Kumamoto Intervention Conference Study,这是一个由 17 家机构组成的日本注册研究,纳入了 2008 年 4 月至 2014 年 3 月期间成功接受 PCI 的连续患者。将患者分为两组:影像引导 PCI 和血管造影引导 PCI。临床结局为 1 年内心脏死亡、非致死性心肌梗死和支架血栓形成的复合事件。共纳入 6025 例 ACS 患者:分别有 3613 例和 2412 例患者接受了影像引导 PCI 和血管造影引导 PCI。影像引导 PCI 组的不良心脏事件发生率显著降低(等级秩和检验 P<0.001)。即使在倾向评分匹配后,两组的事件发生率仍存在显著差异(对数秩检验 P=0.004)。为了评估影像使用频率的影响,我们将 17 家机构分为六组:低频率组、中频率组和高频率组。事件发生率随着影像使用频率的增加而降低,这似乎是由血管造影引导 PCI 中逐步抑制事件驱动的。在日本 ACS 患者中,接受影像引导 PCI 治疗的患者不良临床事件的发生率明显低于接受血管造影引导 PCI 治疗的患者。使用血管内影像更频繁的机构获得了更好的临床结果。日本临床试验注册机构(UMIN)(http://www.umin.ac.jp/ctr/)。标识符:KICS(UMIN000015397)。